Born with a hearing impairment and facing blindness from Usher syndrome, Conner and his family are actively involved in advancing research to prevent vision loss from this genetic condition. But young Conner is not alone- learn about his best buddy Lauren’s selfless efforts to help her friend and their amazing story of friendship, hope and Casey’s groundbreaking work to treat this rare, inherited disease.
Casey Begins First Gene Therapy Study For Usher Syndrome
Michelle Kopf is the first patient to participate in a two-year study that was designed to halt vision loss in people with genes linked to Usher syndrome.
LCA Gene Discovery
For nearly three years, Troy and Jennifer Stevens struggled to learn the identity of the gene responsible for their son Gavin's blindness. With the help of Casey genetic expert John Chiang, PhD, they were able to expand their understanding, while discovering a new gene in the process.
Casey LCA Gene Therapy Treatment featured in the Oregonian
The Oregonian featured a Casey patient who was treated for Leber Congenital Amaurosis (LCA) as part of a clinical trial. LCA is the most common cause of inherited blindness in children, but this gene therapy clinical trial offers new hope.
Seattle Times Features Gene Therapy Patient
Two Seattle-area brothers were treated for Leber Congential Amaurosis (LCA) as part of the LCA Gene Therapy trial at Casey Eye Institute.
Casey Eye Institute is a leader in eye care. To share knowledge about new and emerging treatments with the eye care community, we publish a newsletter, In Full View, two times a year.
The Macular Degeneration Center at Casey Eye Institute, OHSU, publishes InSight, a newsletter about new developments in treating and living with this condition. Macular degeneration is the leading cause of vision loss and blindness in the United States.Download the latest Macular Degeneration Center newsletter